DEA, Marijuana and administrative law judge

Justice Department Says Marijuana Rescheduling Case Should Be Paused In Federal Court After DEA Cancels Hearings
The Justice Department is telling a federal court that it should pause a lawsuit challenging the Drug Enforcement Administration’s (DEA) marijuana rescheduling process after the agency’s own judge cancelled upcoming administrative hearings that were set to start next week.
DEA Judge Cancels Marijuana Rescheduling Hearing Set For Next Week
A DEA judge cancelled a hearing to consider a proposal to reclassify marijuana amid allegations that officials at the agency improperly conferred with witnesses.
Judge postpones DEA hearing on proposed rescheduling of marijuana
A last-minute Biden administration effort to loosen restrictions on marijuana by rescheduling, or reclassifying it, as a less dangerous drug has come up short. An administrative law judge nixed a DEA hearing on the proposed rescheduling of marijuana set to take place next week,
Don’t Blame DEA For Marijuana Rescheduling Hearing Cancellation Caused By Cannabis Industry Lawyers (Op-Ed)
Counsel for the parties fundamentally misunderstood how this proceeding, this tribunal and this judge are legally-bound to proceed—and in so doing have potentially set back the entire movement for cannabis reform.
DEA marijuana rescheduling hearing cancelled following legal challenge
A Drug Enforcement Agency hearing that was scheduled for Jan. 21 to discuss the Biden Administration's plans to reschedule marijuana has been cancelled due to a legal challenge from those who want the rescheduling to go through.
Marijuana rescheduling judge blasts DEA for ‘unprecedented, astonishing’ behavior
DEA's refusal to comply with direct orders is “unprecedented and astonishing," says the judge overseeing the marijuana rescheduling hearing.
DEA judge postpones cannabis rescheduling hearings, Marijuana Moment reports
DEA Administrative Law Judge John Mulrooney has canceled the first hearings on the proposal to reschedule cannabis to a Schedule III drug after
Cannabis Stocks Pull Back After DEA Postpones Rescheduling Hearings
AdvisorShares Pure US Cannabis, a popular exchange-traded fund tracking marijuana stocks, slid 3.6% to $3.44 on Thursday, hovering near an all-time low hit the day before. Shares of the biggest cannabis stocks, including Curaleaf Holdings, Green Thumb Industries and Trulieve Cannabis were down between 3% and 6%.
2DEA Judge Cancels Marijuana Rescheduling Hearing Amid 'Disturbing'...
Biden's proposal to ease restrictions on marijuana was delayed due to allegations of misconduct against the DEA.
KJZZ18h
Federal government effort to reclassify marijuana as less dangerous on hold
The federal government labels marijuana as a schedule one drug in the same category as LSD, peyote and heroin. An effort to ...
Cannabis and Trump 2.0: 2025 and beyond
Alexander Malyshev and Sarah Ganley of Carter Ledyard & Milburn LLP discuss what the cannabis sector can expect as 2025 ...
Brian Cuban to Represent CBIH in DEA Hearings on Marijuana Reclassification
CBIH is proud to announce that Brian Cuban, Esq., a distinguished attorney, best-selling author, mental health advocate, and esteemed member of our Advisory Board, has officially joined the ...
Marijuana Moment2d
DEA Declines To Say Where It Stands On Marijuana Rescheduling In New Legal Filing Reacting To Claims It Conspired With Opponents
The Drug Enforcement Administration (DEA) is asking an agency judge to reject a request to have it removed from upcoming ...